Clinical picture and outcome of Serious Adverse Events in the treatment of Onchocerciasis.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 14975063)

Published in Filaria J on October 24, 2003

Authors

Kwablah Awadzi1

Author Affiliations

1: Onchocerciasis Chemotherapy Research Centre (OCRC) Hohoe Hospital, Hohoe, Ghana. awadzi@ghana.com

Articles citing this

Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study. Med Microbiol Immunol (2007) 2.04

Nodding syndrome in Mundri county, South Sudan: environmental, nutritional and infectious factors. Afr Health Sci (2013) 1.20

A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection. PLoS Negl Trop Dis (2014) 1.04

Doxycycline Leads to Sterility and Enhanced Killing of Female Onchocerca volvulus Worms in an Area With Persistent Microfilaridermia After Repeated Ivermectin Treatment: A Randomized, Placebo-Controlled, Double-Blind Trial. Clin Infect Dis (2015) 0.94

Situation analysis of parasitological and entomological indices of onchocerciasis transmission in three drainage basins of the rain forest of South West Cameroon after a decade of ivermectin treatment. Parasit Vectors (2015) 0.92

Validation of a remote sensing model to identify Simulium damnosum s.l. breeding sites in Sub-Saharan Africa. PLoS Negl Trop Dis (2013) 0.81

A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis. Parasit Vectors (2014) 0.81

Phenotypic and molecular analysis of the effect of 20-hydroxyecdysone on the human filarial parasite Brugia malayi. Int J Parasitol (2016) 0.78

Pharmacokinetic comparison of different flubendazole formulations in pigs: A further contribution to its development as a macrofilaricide molecule. Int J Parasitol Drugs Drug Resist (2015) 0.77

Identification of genes containing ecdysone response elements in the genome of Brugia malayi. Mol Biochem Parasitol (2012) 0.76

Identification of Ecdysone Hormone Receptor Agonists as a Therapeutic Approach for Treating Filarial Infections. PLoS Negl Trop Dis (2016) 0.76

Articles cited by this

Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet (2002) 7.25

Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet (1997) 4.98

Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control. World Health Organ Tech Rep Ser (1995) 2.89

Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet (2001) 1.82

Effects of suramin on ocular onchocerciasis. Tropenmed Parasitol (1976) 1.57

Suramin: with special reference to onchocerciasis. Adv Pharmacol Chemother (1978) 1.45

Letter: Collapse during treatment of onchocerciasis with diethylcarbamazine. Trans R Soc Trop Med Hyg (1974) 1.41

Observations on the chemotherapy of onchocerciasis in Bahr el Ghazal Province, Sudan. Bull World Health Organ (1957) 1.40

Effects of diethylcarbamazine on ocular onchocerciasis. Tropenmed Parasitol (1976) 1.38

Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. Bull World Health Organ (1989) 1.37

Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions. J Infect Dis (2002) 1.36

Microfilariae in the cerebrospinal fluid, and neurological complications, during treatment of onchocerciasis with diethylcarbamazine. Tropenmed Parasitol (1976) 1.18

The Mazzotti reaction following treatment of onchocerciasis with diethylcarbamazine: clinical severity as a function of infection intensity. Am J Trop Med Hyg (1985) 1.17

Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate. Br J Ophthalmol (1980) 1.07

Chemotherapy of onchocerciasis: a controlled comparison of mebendazole, levamisole, and diethylcarbamazine. Lancet (1981) 1.05

Comparison of the effects of a single dose and of four six-monthly doses of ivermectin on adult Onchocerca volvulus. Am J Trop Med Hyg (1991) 1.03

Dangerous reactions to treatment of onchocerciasis with diethylcarbamazine. Br Med J (1977) 1.03

Eosinophil degranulation. An immunologic determinant in the pathogenesis of the Mazzotti reaction in human onchocerciasis. J Immunol (1990) 1.01

The risk of optic atrophy following suramin treatment of ocular onchocerciasis. Bull World Health Organ (1979) 1.00

Effects of three-month doses of ivermectin on adult Onchocerca volvulus. Am J Trop Med Hyg (1992) 0.99

Effects of multiple monthly doses of ivermectin on adult Onchocerca volvulus. Am J Trop Med Hyg (1990) 0.99

Fatalities after treatment of onchocerciasis with diethylcarbamazine. Trans R Soc Trop Med Hyg (1969) 0.98

The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana. Ann Trop Med Parasitol (1986) 0.96

The effect of repeated doses of ivermectin on adult female Onchocerca volvulus in Sierra Leone. Trop Med Parasitol (1992) 0.95

Comparison of flubendazole and diethylcarbamazine in treatment of onchocerciasis. Lancet (1983) 0.93

Effects of a single dose of metrifonate on the forest strain of Onchocerca volvulus in Cameroon. Tropenmed Parasitol (1977) 0.93

The chemotherapy of onchocerciasis XVII. A clinical evaluation of albendazole in patients with onchocerciasis; effects of food and pretreatment with ivermectin on drug response and pharmacokinetics. Trop Med Parasitol (1994) 0.91

Concurrent parasitic infections in onchocerciasis and the occurrence of adverse reactions after ivermectin treatment. Am J Trop Med Hyg (1993) 0.91

The chemotherapy of onchocerciasis II. Quantitation of the clinical reaction to microfilaricides. Ann Trop Med Parasitol (1980) 0.91

Eosinophil sequestration and activation are associated with the onset and severity of systemic adverse reactions following the treatment of onchocerciasis with ivermectin. J Infect Dis (1999) 0.89

The chemotherapy of onchocerciasis. XV. Studies with albendazole. Trop Med Parasitol (1991) 0.89

Eotaxin and RANTES expression by the dermal endothelium is associated with eosinophil infiltration after ivermectin treatment of onchocerciasis. Clin Immunol (2000) 0.88

Neutrophil activation in ivermectin-treated onchocerciasis patients. Clin Exp Immunol (1993) 0.87

Notes and observations on onchocerciasis in Guatemala. Bull World Health Organ (1957) 0.87

The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment. Ann Trop Med Parasitol (1997) 0.85

RANTES in onchocerciasis: changes with ivermectin treatment. Clin Exp Immunol (1996) 0.85

Diethylcarbamazine in the treatment of patients with onchocerciasis. Br J Clin Pharmacol (1992) 0.84

A preliminary report on the out-patient treatment of onchocerciasis with antrypol in the West Nile District of Uganda. East Afr Med J (1955) 0.83

[Attempt at a collective treatment with diethylcarbamazine in a village in the region of Bamako (Mali) where onchocerciasis is hyperendemic]. Bull World Health Organ (1976) 0.83

The chemotherapy of onchocerciasis VIII Levamisole and its combination with the benzimidazoles. Ann Trop Med Parasitol (1982) 0.82

Histopathological studies on suramin toxicity in a chimpanzee. Tropenmed Parasitol (1977) 0.82

The chemotherapy of onchocerciasis IV. Further trials with metrifonate. Ann Trop Med Parasitol (1980) 0.81

Association of transient dermal mastocytosis and elevated plasma tryptase levels with development of adverse reactions after treatment of onchocerciasis with ivermectin. J Infect Dis (2002) 0.81

Reactions to ivermectin treatment in onchocerciasis patients. Acta Leiden (1990) 0.80

C-reactive protein and interleukin-6 are elevated in onchocerciasis patients after ivermectin treatment. J Infect Dis (1994) 0.79

Adverse events following mass ivermectin therapy for onchocerciasis. Trans R Soc Trop Med Hyg (1992) 0.79

Albendazole in the treatment of onchocerciasis: double-blind clinical trial in Venezuela. Am J Trop Med Hyg (1992) 0.78

Studies of metrifonate in onchocerciasis. Acta Pharmacol Toxicol (Copenh) (1981) 0.77

Adverse reactions to ivermectin in reactive onchodermatitis. Lancet (1991) 0.77

Research notes from the Onchocerciasis Chemotherapy Research Centre, Ghana. Ann Trop Med Parasitol (1997) 0.76

The effects of drugs on Onchocerca volvulus. 4. Trials of melarsonyl potassium. Bull World Health Organ (1970) 0.76

[PARTIAL ACCOUNT (752 CASES) OF THE TREATMENT OF ONCHOCERCIASIS IN VENEZUELA WITH SURAMIN SODIUM]. Rev Venez Sanid Asist Soc (1964) 0.76